Percutaneous autologous bone marrow-derived mesenchymal stromal cell implantation is safe for reconstruction of human lower limb long bone atrophic nonunion
Cell Journal [Yakhteh]. 2017; 19 (1): 159-165
en Inglés
| IMEMR
| ID: emr-185802
ABSTRACT
Objective:
Nonunion is defined as a minimum of a 9-month period of time since an injury with no visibly progressive signs of healing for 3 months. Recent studies show that application of mesenchymal stromal cells [MSCs] in the laboratory setting is effective for bone regeneration. Animal studies have shown that MSCs can be used to treat nonunions. For the first time in an Iranian population, the present study investigated the safety of MSC implantation to treat human lower limb long bone nonunion
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Trasplante Autólogo
/
Estudios Prospectivos
/
Procedimientos de Cirugía Plástica
/
Extremidad Inferior
/
Células Madre Mesenquimatosas
/
Autoinjertos
Tipo de estudio:
Ensayo Clínico Controlado
Límite:
Adolescente
/
Adulto
/
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Cell J. [Yakhteh]
Año:
2017
Similares
MEDLINE
...
LILACS
LIS